BOSTON SCIENTIFIC CORPORATION Debt Securities UNDERWRITING AGREEMENT-BASIC PROVISIONSUnderwriting Agreement • November 12th, 2019 • Boston Scientific Corp • Surgical & medical instruments & apparatus • New York
Boston Scientific Corporation (the “Company”) proposes to issue and sell its Debt Securities having an aggregate principal amount of €900,000,000 (the “Securities”). The Securities will be issued under an indenture dated as of May 29, 2013 between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented from time to time by supplemental indentures and/or modified from time to time by resolutions of the Board of Directors of the Company, Pricing Certificate of Authorized Officers thereof or Officer’s Certificate as provided in Section 301 of such indenture (such indenture as so supplemented and/or modified being hereinafter referred to as the “Indenture”).
THIS NOTE IS A GLOBAL NOTE WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE COMMON DEPOSITARY (AS DEFINED IN THE INDENTURE GOVERNING THIS NOTE) OR A NOMINEE OF THE COMMON DEPOSITARY. THIS NOTE IS NOT...Indenture • November 12th, 2019 • Boston Scientific Corp • Surgical & medical instruments & apparatus • New York
Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at this place.
